产品标题 产品货号 产品规格 厂家
Male-specific lethal 2 homolog (Drosophila) (MSL2), transcript variant 2 from ORIGENE TECHNOLOGIESLY428876100 ugORIGENE TECHNOLOGIES
Malic enzyme 2, NAD(+)-dependent, mitochondrial (ME2), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESLY419348100 ugORIGENE TECHNOLOGIES
Male-specific lethal 3 homolog (Drosophila) (MSL3), transcript variant 4 from ORIGENE TECHNOLOGIESLY409197100 ugORIGENE TECHNOLOGIES
Malic enzyme 3, NADP(+)-dependent, mitochondrial (ME3), nuclear gene encoding mitochondrial protein, transcript variant 2 from ORIGENE TECHNOLOGIESLY423083100 ugORIGENE TECHNOLOGIES
Malignant T cell amplified sequence 1 (MCTS1), transcript variant 1 from ORIGENE TECHNOLOGIESLY415503100 ugORIGENE TECHNOLOGIES
Malignant fibrous histiocytoma amplified sequence 1 (MFHAS1) from ORIGENE TECHNOLOGIESLY418133100 ugORIGENE TECHNOLOGIES
Malic enzyme 1, NADP(+)-dependent, cytosolic (ME1) from ORIGENE TECHNOLOGIESLY400854100 ugORIGENE TECHNOLOGIES
MAL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4012561 kitORIGENE TECHNOLOGIES
Mal - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5096821 kitORIGENE TECHNOLOGIES
Mal2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5096831 kitORIGENE TECHNOLOGIES
MALL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4013781 kitORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6024675x5umORIGENE TECHNOLOGIES
MAL2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4038621 kitORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054365x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6024685x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6024695x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054385x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054375x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054395x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054425x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054405x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054435x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060015x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060025x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6054415x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060035x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060055x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060065x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060075x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060045x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060085x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060095x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060105x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6072745x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060115x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6072755x5umORIGENE TECHNOLOGIES
Human Liver; Fatty changes to liver from ORIGENE TECHNOLOGIESCS6060135x5umORIGENE TECHNOLOGIES
Nascent polypeptide-associated complex alpha subunit (NACA), transcript variant 2 from ORIGENE TECHNOLOGIESLY426388100 ugORIGENE TECHNOLOGIES
Nascent polypeptide-associated complex alpha subunit 2 (NACA2) from ORIGENE TECHNOLOGIESLY404610100 ugORIGENE TECHNOLOGIES
NASP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4040521 kitORIGENE TECHNOLOGIES
Nascent polypeptide-associated complex alpha subunit (NACA), transcript variant 4 from ORIGENE TECHNOLOGIESLY426389100 ugORIGENE TECHNOLOGIES
Nascent polypeptide-associated complex alpha subunit (NACA), transcript variant 3 from ORIGENE TECHNOLOGIESLY417201100 ugORIGENE TECHNOLOGIES
Nasp - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5107411 kitORIGENE TECHNOLOGIES
NAT8B Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31564710 ugORIGENE TECHNOLOGIES
NAT8B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4156471 kitORIGENE TECHNOLOGIES
NASP Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30405210 ugORIGENE TECHNOLOGIES
Nat8f1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035151 kitORIGENE TECHNOLOGIES
Nat8f2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035161 kitORIGENE TECHNOLOGIES
NAT1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2210421 kitORIGENE TECHNOLOGIES
NAT1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN221042BN1 kitORIGENE TECHNOLOGIES
 |< < 1270 1271 1272 1273 1274 1275 1276 1277 1278 > >| 第 1277/6274 页